Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
- NCT04383210
- 21/195 UNIVERSITY OF SYDNEY - ELVCAP-001-01 - MOST CRESTONE - CT1435
Trial sponsor
Elevation Oncology
Scientific Title
A Phase 2 Study of Seribantumab in Adult Patients With Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors